Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020722 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Nicolás J Garrido und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Virgen de la Luz Hospital, 16002 Cuenca, Spain. Hauptthemen laut MEDLINE: COVID-19, Biomarkers, Emergency Service, Hospital, Artificial Intelligence. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Castilla-La Mancha.
Abstract (Originalsprache)
The COVID-19 pandemic has accelerated advances in molecular biology and virology, enabling the identification of key biomarkers to differentiate between severe and mild cases. Furthermore, the use of artificial intelligence (AI) and machine learning (ML) to analyze large datasets has been crucial for rapidly identifying relevant biomarkers for disease prognosis, including COVID-19. This approach enhances diagnostics in emergency settings, allowing for more accurate and efficient patient management. This study demonstrates how machine learning algorithms in emergency departments can rapidly identify key biomarkers for the vital prognosis in an emerging pandemic using COVID-19 as an example by analyzing clinical, epidemiological, analytical, and radiological data. All consecutively admitted patients were included, and more than 89 variables were processed using the Random Forest (RF) algorithm. The RF model achieved the highest balanced accuracy at 92.61%. The biomarkers most predictive of mortality included procalcitonin (PCT), lactate dehydrogenase (LDH), and C-reactive protein (CRP). Additionally, the system highlighted the significance of interstitial infiltrates in chest X-rays and D-dimer levels. Our results demonstrate that RF is crucial in identifying critical biomarkers in emerging diseases, accelerating data analysis, and optimizing prognosis and personalized treatment, emphasizing the importance of PCT and LDH in high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine, Virgen de la Luz Hospital, 16002 Cuenca, Spain.
- Expert Medical Analysis Group, Institute of Technology, University of Castilla-La Mancha, 16071 Cuenca, Spain.
- Expert Medical Analysis Group, Instituto de Investigación Sanitaria de Castilla-La Mancha (IDISCAM), 45071 Toledo, Spain.
- Department of Emergency Medicine, Virgen de la Luz Hospital, 16002 Cuenca, Spain.
- Department of Pharmacy, General University Hospital, 46014 Valencia, Spain.
Förderung
- University of Castilla-La Mancha
Zitieren
APA
Garrido, N. J., González-Martínez, F., Torres, A. M., Blasco-Segura, P., Losada, S., Plaza, A., & Mateo, J. (2025). Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020722
Vancouver
Garrido NJ, González-Martínez F, Torres AM, Blasco-Segura P, Losada S, Plaza A, et al. Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020722
BibTeX
@article{Garrido2025,
author = {Garrido, Nicolás J and González-Martínez, Félix and Torres, Ana M and Blasco-Segura, Pilar and Losada, Susana and Plaza, Adrián and Mateo, Jorge},
title = {Role of Artificial Intelligence in Identifying Vital Biomarkers with Greater Precision in Emergency Departments During Emerging Pandemics},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020722}
}
EUVIMED